Veyong gafere EU EDQM Audit ọzọ

N’April 22, ozi ọma bịara!Hebei Veyong Pharmaceutical Co., Ltd. ọzọ nwetakwara EU CEP asambodo makaivermectinAPI nke European Agency for the Quality of Medicine (EDQM) nyere.

IvermectinAPI bụ otu n'ime isi ngwaahịa Veyong Pharma.Ndị ahịa na-anabata ya nke ọma n'ụlọ na mba ọzọ n'ihi nkwụsi ike ya siri ike, àgwà dị elu na usoro mmepụta akwụkwọ ndụ akwụkwọ ndụ.Na 2018, ọ nwetara asambodo FDA US nke ọma.

Asambodo ivermectin CEP bụ akwụkwọ ikike mgbanwe nke European Pharmacopoeia, nke ọ bụghị naanị na mba EU niile ghọtara, mana ọtụtụ mba ghọtara ọkwa European Pharmacopoeia.Inweta asambodo CEP ọzọ bụ nnabata nke ngwaahịa Veyong Pharma n'ahịa mba ụwa, njiri mara asọmpi ahịa Veyong, yana akara dị ịrịba ama nke inweta mmepe azụmaahịa dị elu n'ahịa mba ofesi.